Cardiac magnetic resonance imaging, especially with the use of late gadolinium enhancement, is a useful modality to diagnose cardiac sarcoidosis and more than twice as sensitive for cardiac involvement as current consensus criteria of modified Japanese Ministry of Health guidelines. The location of hyperenhancement in cardiac sarcoidosis tends to be varied; however, there is a predilection for the basal or mid-ventricular septum in the majority of the cases. Hyperenhancement reflects myocardial damage, which is reported to be associated with future events of ventricular arrhythmia and poor outcome.
Supplementary material is available at European Heart Journal online.
